Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects of cancer treatment1-3.Inadequately controlled emesis significantly impairs quality of life1.
e-MANAgE is a tool in the form of an App to guide physician in evaluating the emetogenecity level of chemotherapy (single/ combination) administered to their patients and in turn better management of CINV
The concept of the e-MANAgE is to provide a reliable method of predicting the risk of emesis following cancer chemotherapy.
This App is developed by MSD Pharmaceuticals Pvt. Ltd., India.
Copyright © 2015 MSD Pharmaceuticals Pvt. Ltd.,
a subsidiary of Merck Sharp & Dohme Corp.,
Whitehouse Station, N.J., U.S.A. All rights reserved.
ONCO-1142625-0000 25/02/2015 24/02/2016
Reference:
1) Hesketh PJ. Defining the emetogenicity of cancer chemotherapy regimens:
relevance to clinical practice. Oncologist. 1999;4(3):191-6.
2) Coates A, Abraham S, Kaye SB, et al. On the receiving end: patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol. 1983;19(2):203-8.
3) Griffin AM, Butow PN, Coates AS, et al. On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol. 1996;7(2):189-95.
This version of MSD CINV App Android App comes with one universal variant which will work on all the Android devices.
If you are looking to download other versions of MSD CINV App Android App, We have 1 version in our database. Please select one of them below to download.